rs750832509
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_005144.5(HR):c.3224_3227dupCCGG(p.Ala1077fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000738 in 1,355,380 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 7.4e-7 ( 0 hom. )
Consequence
HR
NM_005144.5 frameshift
NM_005144.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.410
Genes affected
HR (HGNC:5172): (HR lysine demethylase and nuclear receptor corepressor) This gene encodes a protein that is involved in hair growth. This protein functions as a transcriptional corepressor of multiple nuclear receptors, including thyroid hormone receptor, the retinoic acid receptor-related orphan receptors and the vitamin D receptors, and it interacts with histone deacetylases. The translation of this protein is modulated by a regulatory open reading frame (ORF) that exists upstream of the primary ORF. Mutations in this upstream ORF cause Marie Unna hereditary hypotrichosis (MUHH), an autosomal dominant form of genetic hair loss. Mutations in this gene also cause autosomal recessive congenital alopecia and atrichia with papular lesions, other diseases resulting in hair loss. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HR | NM_005144.5 | c.3224_3227dupCCGG | p.Ala1077fs | frameshift_variant | 17/19 | ENST00000381418.9 | NP_005135.2 | |
HR | NM_018411.4 | c.3214-601_3214-598dupCCGG | intron_variant | NP_060881.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HR | ENST00000381418.9 | c.3224_3227dupCCGG | p.Ala1077fs | frameshift_variant | 17/19 | 1 | NM_005144.5 | ENSP00000370826.4 | ||
HR | ENST00000680789.1 | c.3224_3227dupCCGG | p.Ala1077fs | frameshift_variant | 18/20 | ENSP00000505181.1 | ||||
HR | ENST00000312841.9 | c.3214-601_3214-598dupCCGG | intron_variant | 5 | ENSP00000326765.8 | |||||
HR | ENST00000522016.1 | n.1417_1420dupCCGG | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000910 AC: 1AN: 109850Hom.: 0 AF XY: 0.0000167 AC XY: 1AN XY: 60060
GnomAD3 exomes
AF:
AC:
1
AN:
109850
Hom.:
AF XY:
AC XY:
1
AN XY:
60060
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 7.38e-7 AC: 1AN: 1355380Hom.: 0 Cov.: 31 AF XY: 0.00000150 AC XY: 1AN XY: 665540
GnomAD4 exome
AF:
AC:
1
AN:
1355380
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
665540
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
HR-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | The HR c.3224_3227dupCCGG (p.Ala1077ArgfsTer69) variant results in a frameshift and is predicted to result in premature termination of the protein. The p.Ala1077ArgfsTer69 variant has been reported in a single study in which it was found in a homozygous state in two affected siblings with alopecia universalis and complete atrichia (Nucara et al. 2011). The variant was also found in a heterozygous state in the unaffected parents and an unaffected sibling. Control data are unavailable for this variant, which is not reported in the 1000 Genomes Project, the Exome Sequencing Project, or the Exome Aggregation Consortium. The variant is in a region of low sequence coverage in both the Exome Sequencing Project and the Exome Aggregation Consortium. Due to the potential impact of frameshift variants and the supporting evidence, the p.Ala1077ArgfsTer69 variant is classified as a variant of unknown significance but suspicious for pathogenicity for HR-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at